SPN-817 trials for Epilepsy

All SPN-817 trials · All Epilepsy trials

Phase breakdown

Recruiting trials studying SPN-817 for Epilepsy

• RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
  NCT06798896 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
  NCT07141329 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
  NCT05518578 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 10 locations

Common questions

How many trials study SPN-817 for Epilepsy?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.